"Given the risks in the world around us and the uncertainty of the global rollout of the vaccine, we can expect our borders to be impacted for much of this year," Ardern said at a news conference. Ardern said the country's medicines regulator Medsafe was working towards granting provisional approval for the Pfizer Inc and BioNTech SE vaccine. A tough lockdown and geographical isolation helped the country of 5 million virtually eliminate the novel coronavirus within its borders. New Zealand reported 2 new cases of COVID-19 at its managed isolation facilities on Tuesday and no new community cases. The country has 65 active cases, 1,934 confirmed cases in all, and 25 deaths.

Source: bd News24 January 26, 2021 05:03 UTC